Financhill
Sell
20

ALZN Quote, Financials, Valuation and Earnings

Last price:
$2.03
Seasonality move :
-32.83%
Day range:
$2.03 - $2.07
52-week range:
$1.88 - $11.70
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
1.46x
Volume:
39.9K
Avg. volume:
78.6K
1-year change:
-80.86%
Market cap:
$6.4M
Revenue:
--
EPS (TTM):
-$5.50

Earnings Data

Next earnings date for ALZN
--
Most recent earnings per share
-$0.30
Beat by $1.66
(Oct 31/2025)
Consensus Estimate
-$1.96
(Oct 31/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

ALZN Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
01/31/2026 Q1 -- -- -- -$0.53 --
10/31/2025 Q4 -- -- -$0.30 -$1.96 $1.66
09/11/2025 Q3 -- -- -$1.28 -$0.69 -$0.59
04/30/2025 Q2 -- -- -$2.22 -$2.70 $0.48
03/10/2025 Q1 -- -- -$1.70 -$3.20 $1.50
12/11/2024 Q4 -- -- -$0.39 -$3.42 $3.03
09/11/2024 Q3 -- -- -$1.25 -$21.42 $20.17
04/30/2024 Q2 -- -- -$1.24 -$34.20 $32.96
03/25/2024 Q1 -- -- -$3.77 -$29.25 $25.48
12/15/2023 Q4 -- -- -$4.43 -$60.75 $56.32
09/13/2023 Q3 -- -- -$5.38 -- --
04/30/2023 Q2 -- -- -$5.13 -- --
03/16/2023 Q1 -- -- -$8.28 -- --
12/12/2022 Q4 -- -- -$4.79 -- --
09/13/2022 Q3 -- -- -$4.67 -- --
04/30/2022 Q2 -- -- -$6.08 -- --
03/15/2022 Q1 -- -- -$4.28 -- --
12/13/2021 Q4 -- -- -$6.08 -- --
09/13/2021 Q3 -- -- -$4.01 -- --
04/30/2021 Q2 -- -- -$19.98 -- --
01/31/2021 Q1 -- -- -$1.93 -- --
10/31/2020 Q4 -- -- -$2.38 -- --
07/31/2020 Q3 -- -- -$19.80 -- --
04/30/2020 Q2 -- -- -$18.90 -- --

Alzamend Neuro, Inc. Earnings Questions

  • How Much did Alzamend Neuro, Inc. Generate in Revenue Last Quarter?

    Alzamend Neuro, Inc. reported -- worth of top line sales in its most recent quarter.

  • Did Alzamend Neuro, Inc. Beat Earnings Last Quarter?

    Alzamend Neuro, Inc. announced earnings per share of -$0.30 which represents a beat of analyst forecast a -$1.96 per share.

  • Is Alzamend Neuro, Inc. Profitable?

    Alzamend Neuro, Inc. reported -$27.7K that represents -$0.01 per share over the last quarter.

  • What is the Analyst Consensus for Alzamend Neuro, Inc. EPS Next Year?

    Alzamend Neuro, Inc.'s earnings are forecast to decrease from -$11.32 per share to -$11.88 per share next year representing a decrease of -53.6%.

  • When is Alzamend Neuro, Inc.'s Earnings Date?

    Currently, Alzamend Neuro, Inc. has not yet stated when its earnings date is, however, based on past estimates it's likely to take place on March 26, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is DocuSign Stock Undervalued?
Is DocuSign Stock Undervalued?

Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…

Is SentinelOne Stock Undervalued?
Is SentinelOne Stock Undervalued?

Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…

Is Broadcom Stock on Sale?
Is Broadcom Stock on Sale?

Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…

Stock Ideas

Buy
57
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 64x

Buy
55
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 37x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Buy
80
TVTX alert for Dec 25

Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.

Buy
68
KOD alert for Dec 25

Kodiak Sciences, Inc. [KOD] is up 13.41% over the past day.

Buy
64
ZCSH alert for Dec 25

Grayscale Zcash Trust (ZEC) [ZCSH] is up 5.33% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock